66th ASH Annual Meeting: Hemoglobinopathies Sessions

Friday, December 6, 2024

top

11:00 AM-2:00 PM

Evolving Treatment Paradigms for Patients with Hemoglobinopathies

Friday Satellite Symposia

1:30 PM-1:40 PM

ASH-a-Palooza

Blood Drop: Sickle Cell Disease

Trainee Activities and Services

1:30 PM-3:50 PM

ASH-a-Palooza

Blood Buddies: Pediatric Clinical Classical Hematology

Trainee Activities and Services

1:50 PM-2:00 PM

ASH-a-Palooza

Blood Drop: Sickle Cell Disease

Trainee Activities and Services

2:40 PM-2:50 PM

ASH-a-Palooza

Blood Drop: Sickle Cell Disease

Trainee Activities and Services

3:00 PM-3:10 PM

ASH-a-Palooza

Blood Drop: Sickle Cell Disease

Trainee Activities and Services

3:20 PM-3:30 PM

ASH-a-Palooza

Blood Drop: Sickle Cell Disease

Trainee Activities and Services

3:40 PM-3:50 PM

ASH-a-Palooza

Blood Drop: Sickle Cell Disease

Trainee Activities and Services

Saturday, December 7, 2024

top

9:00 AM-7:30 PM

Poster Session I - Viewing

Events

9:30 AM-10:45 AM

Ineffective Erythropoiesis: Insights Into Molecular Mechanisms and Disease Pathophysiology

Scientific Program

Optimizing Non-Curative Therapies for Sickle Cell Disease

Education Program

9:30 AM-11:00 AM

102. Iron Homeostasis and Biology: New Insights into Iron-related Proteins in Erythropoiesis and Inflammation

Oral and Poster Abstracts

401. Blood Transfusion: Advancements in Transfusion Science

Oral and Poster Abstracts

11:15 AM-12:15 PM

Career Development Lunch

Trainee Activities and Services

12:00 PM-1:30 PM

711. Cell Collection and Manufacturing of HSPCs, CAR-T Cells, and Other Cellular Therapy Products: Innovations in Mobilization, Collection, and Manufacturing for Cellular Therapies

Oral and Poster Abstracts

802. Chemical Biology and Experimental Therapeutics: Novel Therapeutic Strategies for Hematologic Disorders: From Mechanistic to Preclinical Studies

Oral and Poster Abstracts

12:30 PM-1:30 PM

2024 Ham-Wasserman Lecture

Marquee Sessions

2:00 PM-3:15 PM

Hematologic Challenges at the End-of-Life

Education Program

Integrating New Therapies into the Management of Classical Heme Disorders

Education Program

2:00 PM-3:30 PM

113. Sickle Cell Disease, Sickle Cell Trait, and Other Hemoglobinopathies, Excluding Thalassemias: Basic and Translational: Identification of New Molecular Targets to Modulate Sickle Cell Disease

Oral and Poster Abstracts

114. Sickle Cell Disease, Sickle Cell Trait, and Other Hemoglobinopathies, Excluding Thalassemias: Clinical and Epidemiological: Therapeutic Advances in Sickle Cell Disease

Oral and Poster Abstracts

Symposium on Quality: Treating Fairly - The Role of Quality Improvement in Combating Health Care Disparities

Special-Interest Sessions

4:00 PM-5:15 PM

Interface of Complement and Coagulation

Scientific Symposia

4:00 PM-5:30 PM

114. Sickle Cell Disease, Sickle Cell Trait, and Other Hemoglobinopathies, Excluding Thalassemias: Clinical and Epidemiological: Tools and Biomarkers for Improving Sickle Cell Disease Treatments

Oral and Poster Abstracts

721. Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Toxicities: Optimizing Outcomes in Pediatric, Adolescent and Young Adult Patients

Oral and Poster Abstracts

904. Outcomes Research: Hemoglobinopathies: Non-Malignant Conditions: Determinants of Health Equity Across the Spectrum

Oral and Poster Abstracts

5:30 PM-7:30 PM

Poster Session I - Presentations (for in-person participants)

Events

101. Red Cells and Erythropoiesis, Excluding Iron: Poster I

Oral and Poster Abstracts

112. Thalassemia and Globin Gene Regulation: Poster I

Oral and Poster Abstracts

113. Sickle Cell Disease, Sickle Cell Trait, and Other Hemoglobinopathies, Excluding Thalassemias: Basic and Translational: Poster I

Oral and Poster Abstracts

114. Sickle Cell Disease, Sickle Cell Trait, and Other Hemoglobinopathies, Excluding Thalassemias: Clinical and Epidemiological: Poster I

Oral and Poster Abstracts

701. Experimental Transplantation: Basic and Translational: Poster I

Oral and Poster Abstracts

711. Cell Collection and Manufacturing of HSPCs, CAR-T Cells, and Other Cellular Therapy Products: Poster I

Oral and Poster Abstracts

721. Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Toxicities: Poster I

Oral and Poster Abstracts

722. Allogeneic Transplantation: Acute and Chronic GVHD and Immune Reconstitution: Poster I

Oral and Poster Abstracts

723. Allogeneic Transplantation: Long-term Follow-up, Complications, and Disease Recurrence: Poster I

Oral and Poster Abstracts

732. Allogeneic Transplantation: Disease Response and Comparative Treatment Studies: Poster I

Oral and Poster Abstracts

801. Gene Therapies: Poster I

Oral and Poster Abstracts

803. Emerging Tools, Techniques, and Artificial Intelligence in Hematology: Poster I

Oral and Poster Abstracts

900. Health Services and Quality Improvement: Hemoglobinopathies: Poster I

Oral and Poster Abstracts

904. Outcomes Research: Hemoglobinopathies: Poster I

Oral and Poster Abstracts

909. Education, Communication, and Workforce: Poster I

Oral and Poster Abstracts

Sunday, December 8, 2024

top

9:00 AM-8:00 PM

Poster Session II - Viewing

Events

9:30 AM-10:45 AM

Interrogating the Impact of the Intestinal Microbiome on Transplant and Cellular Therapies

Scientific Symposia

9:30 AM-11:00 AM

112. Thalassemia and Globin Gene Regulation: We're Going to Catch a Big One: Towards Targeted Therapies in Thalassemia

Oral and Poster Abstracts

801. Gene Therapies: Gene Editing and Replacement Therapies for Hemoglobinopathies: From Bench to Bedside

Oral and Poster Abstracts

900. Health Services and Quality Improvement: Hemoglobinopathies: Navigating and Optimizing Healthcare Systems

Oral and Poster Abstracts

Sickle Cell Disease Centers Session

Special-Interest Sessions

12:00 PM-1:30 PM

114. Sickle Cell Disease, Sickle Cell Trait, and Other Hemoglobinopathies, Excluding Thalassemias: Clinical and Epidemiological: Improving Outcomes in Sickle Cell Disease Around the World

Oral and Poster Abstracts

900. Health Services and Quality Improvement: Hemoglobinopathies: Empowering Choices: Navigating Shared Decision-Making for Patient-Centric Care

Oral and Poster Abstracts

4:30 PM-5:45 PM

Curative Therapies for Sickle Cell Disease: Option for Some but Not Quite All

Spotlight Sessions

4:30 PM-6:00 PM

113. Sickle Cell Disease, Sickle Cell Trait, and Other Hemoglobinopathies, Excluding Thalassemias: Basic and Translational: Attenuating Sickle Cell Disease Complications – Lessons from Pre-clinical Models

Oral and Poster Abstracts

6:00 PM-8:00 PM

Poster Session II - Presentations (for in-person participants)

Events

101. Red Cells and Erythropoiesis, Excluding Iron: Poster II

Oral and Poster Abstracts

102. Iron Homeostasis and Biology: Poster II

Oral and Poster Abstracts

112. Thalassemia and Globin Gene Regulation: Poster II

Oral and Poster Abstracts

113. Sickle Cell Disease, Sickle Cell Trait, and Other Hemoglobinopathies, Excluding Thalassemias: Basic and Translational: Poster II

Oral and Poster Abstracts

114. Sickle Cell Disease, Sickle Cell Trait, and Other Hemoglobinopathies, Excluding Thalassemias: Clinical and Epidemiological: Poster II

Oral and Poster Abstracts

330. Vascular Biology, Thrombosis, and Thrombotic Microangiopathies: Basic and Translational: Poster II

Oral and Poster Abstracts

401. Blood Transfusion: Poster II

Oral and Poster Abstracts

722. Allogeneic Transplantation: Acute and Chronic GVHD and Immune Reconstitution: Poster II

Oral and Poster Abstracts

801. Gene Therapies: Poster II

Oral and Poster Abstracts

900. Health Services and Quality Improvement: Hemoglobinopathies: Poster II

Oral and Poster Abstracts

904. Outcomes Research: Hemoglobinopathies: Poster II

Oral and Poster Abstracts

905. Outcomes Research: Non-Malignant Conditions Excluding Hemoglobinopathies: Poster II

Oral and Poster Abstracts

Monday, December 9, 2024

top

9:00 AM-8:00 PM

Poster Session III - Viewing

Events

10:30 AM-11:45 AM

Challenges and Opportunities of Sickle Cell Care in Africa

Education Program

10:30 AM-12:00 PM

905. Outcomes Research: Non-Malignant Conditions Excluding Hemoglobinopathies: Innovative Approaches to Improve Care for Understudied Non-Malignant Hematologic Diseases

Oral and Poster Abstracts

12:15 PM-1:15 PM

Energizing Red Blood Cells: The Latest Data in Thalassemia

Industry Theaters

1:30 PM-2:30 PM

Ernest Beutler Lecture and Prize

Marquee Sessions

2:45 PM-4:00 PM

Iron at the Crossroads Between Erythropoiesis and Megakaryopoiesis

Spotlight Sessions

2:45 PM-4:15 PM

114. Sickle Cell Disease, Sickle Cell Trait, and Other Hemoglobinopathies, Excluding Thalassemias: Clinical and Epidemiological: The Effects of Sickle Cell Disease on Organ Function

Oral and Poster Abstracts

4:30 PM-6:00 PM

904. Outcomes Research: Hemoglobinopathies: Non-Malignant Conditions: Transforming Care: Insights into Healthcare Utilization, Outcome Measurement, and Treatment Impact in Sickle Cell Disease

Oral and Poster Abstracts

ASH Research Collaborative Data Hub Sickle Cell Disease Network: Accelerating Research and Collaborative Clinical Care through Real-World Evidence Generation

Special-Interest Sessions

6:00 PM-8:00 PM

Center for Sickle Cell Disease Initiatives: Advancing Progress in Sickle Cell Disease Update and Reception: hosted by ASH and ASH Research Collaborative

Special-Interest Sessions

Poster Session III - Presentations (for in-person participants)

Events

101. Red Cells and Erythropoiesis, Excluding Iron: Poster III

Oral and Poster Abstracts

102. Iron Homeostasis and Biology: Poster III

Oral and Poster Abstracts

112. Thalassemia and Globin Gene Regulation: Poster III

Oral and Poster Abstracts

113. Sickle Cell Disease, Sickle Cell Trait, and Other Hemoglobinopathies, Excluding Thalassemias: Basic and Translational: Poster III

Oral and Poster Abstracts

114. Sickle Cell Disease, Sickle Cell Trait, and Other Hemoglobinopathies, Excluding Thalassemias: Clinical and Epidemiological: Poster III

Oral and Poster Abstracts

401. Blood Transfusion: Poster III

Oral and Poster Abstracts

701. Experimental Transplantation: Basic and Translational: Poster III

Oral and Poster Abstracts

801. Gene Therapies: Poster III

Oral and Poster Abstracts

803. Emerging Tools, Techniques, and Artificial Intelligence in Hematology: Poster III

Oral and Poster Abstracts

900. Health Services and Quality Improvement: Hemoglobinopathies: Poster III

Oral and Poster Abstracts

904. Outcomes Research: Hemoglobinopathies: Poster III

Oral and Poster Abstracts

Tuesday, December 10, 2024

top

9:45 AM-11:15 AM

2024 Presidential Symposium

Marquee Sessions